当前位置:Public Access >检索试验
Chinese/English
Filter Options

Public title

Verify status

Pay status

Study ailment

Study type

Study phase

       More Options
Reg No. in ChiCTR Public title Ailment Type Phase Registration time Viewed Operation
ChiCTR2300071381

Adjuvant treatment of stage IIIC-IIID (lymph node micrometastasis) acral melanoma with Carelizumab combined with Temozolomide versus Carelizumab alone, in addition of radiation therapy: a single center, open label, randomized, controlled Phase II study

Fudan University Shanghai Cancer Center

Melanoma

Therapy Study

Post-market

2023-08-15 717 Patient list
ChiCTR2100053984

A comparative study of 68GA-FAPI and 18F-FDG in the diagnosis of malignant tumors

Fudan University Shanghai Cancer Center

malignant tumor

Diagnostic Accuracy Test

Premarket

2021-12-05 968 Patient list
ChiCTR2100049563

A single-arm, Phase II Study to toripalimab combined with pazopanib in treatment of patients with simple lung metastasis clear cell renal cell carcinoma before operation

Fudan University Shanghai Cancer Center

2021-08-02 1140 Patient list
ChiCTR2000029654

Efficiency and safety of Anlotinib in platinum resistant or refractory ovarian cancer: a prospective, single arm, single center, exploratory phase 2 clinical trail

Fudan University Shanghai Cancer Center

Diagnostic Accuracy Test

Post-market

2020-02-08 2380 Patient list

Efficacy and safety of paclitaxel (albumin-binding) combined with carboplatin for neoadjuvant therapy for unresectable ovarian cancer in women: a single-center, open, one-arm, phase Ib, and phase II clinical study

Fudan University Shanghai Cancer Center

ovarian cancer

Therapy Study

Post-market

2019-10-25 1449 Patient list
ChiCTR1900025421

The association between nutritional metabolism, DNA methylation and endometrial cancer

Fudan University Shanghai Cancer Center

Therapy Study

Premarket

2019-08-14 1070 Patient list
ChiCTR1800018965

Efficacy and safety of apatinib mesylate in the treatment of recurrent uterine malignancies with failure of second-line and above chemotherapy

Fudan University Shanghai Cancer Center

Diagnostic Accuracy Test

Post-market

2018-10-19 1343 Patient list
ChiCTR1800018754

Prognostic Value of Plasma ctDNA mutation patterns in Stage III Colon Cancer

Fudan University Shanghai Cancer Center

Therapy Study

Post-market

2018-10-08 1434 Patient list
ChiCTR1800018108

Choosing Optimal Microcarcinoma Patients for Active Surveillance Study (COMPASS) - Efficacy of a pre-operative clinical framework

Fudan University Shanghai Cancer Center

papillary thyroid microcarcinoma

2018-08-31 1266 Patient list
ChiCTR-IIR-17013683

A Phase III trial of intensity modulated radiation therapy for pelvic and/or para-aortic nodes and intra-cavitary brachytherapy combined with chemotherapy for stage IIb-IVa cervical cancer

Fudan University Shanghai Cancer Center

Cervical Cancer

Therapy Study

Post-market

2017-12-05 1211 Patient list